NEVVI Medicare utilization intelligence

← back

MANUELIDIS, LAERTESM.D. NPI 1245220698 Clinician

Dermatology · FORT MYERS, FL

Specialty Dermatology — from billed Medicare claims
Trained YALE UNIVERSITY SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 29 years since medical school (class of 1997, self-reported to CMS)
Location FORT MYERS, FL · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 57 codes billed · 32,874 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-09

Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were premium in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
J3245 Injection, tildrakizumab, 1 mg premiumpremium premiumpremium
88305 Pathology examination of tissue using a microscope, intermediate complexity premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
17003 Destruction of precancer skin growth, 2-14 growths premiumpremium premiumpremium
17000 Destruction of precancer skin growth, 1 growth premiumpremium premiumpremium
88341 Special stained specimen slides to examine tissue, each additional procedure premiumpremium premiumpremium
88342 Special stained specimen slides to examine tissue, initial procedure premiumpremium premiumpremium
Q4277 Woundplus membrane or e-graft, per square centimeter premiumpremium premiumpremium
17110 Destruction of skin growth, 1-14 growths premiumpremium premiumpremium
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm premiumpremium premiumpremium
11302 Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm premiumpremium premiumpremium
17004 Destruction of precancer skin growth, 15 or more growths premiumpremium premiumpremium
Q4303 Complete aa, per square centimeter premiumpremium premiumpremium
15271 Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less premiumpremium premiumpremium
88304 Pathology examination of tissue using a microscope, moderately low complexity premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
11102 Biopsy of related skin growth, first growth premiumpremium premiumpremium
11311 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm premiumpremium premiumpremium
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm premiumpremium premiumpremium
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more premiumpremium premiumpremium
88312 Special stained specimen slides to identify organisms including interpretation and report premiumpremium premiumpremium
Q4326 Woundplus, per square centimeter premiumpremium premiumpremium
17281 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm premiumpremium premiumpremium
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm premiumpremium premiumpremium
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more premiumpremium premiumpremium
11306 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm premiumpremium premiumpremium
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm premiumpremium premiumpremium
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm premiumpremium premiumpremium
17271 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm premiumpremium premiumpremium
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm premiumpremium premiumpremium
17282 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm premiumpremium premiumpremium
11312 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm premiumpremium premiumpremium
11307 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm premiumpremium premiumpremium
11103 Biopsy of related skin growth, each additional growth premiumpremium premiumpremium
17111 Destruction of skin growth, 15 or more growths premiumpremium premiumpremium
67810 Biopsy of eyelid premiumpremium premiumpremium
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg premiumpremium premiumpremium
11104 Punch biopsy, first skin growth premiumpremium premiumpremium
11310 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less premiumpremium premiumpremium
11642 Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm premiumpremium premiumpremium
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm premiumpremium premiumpremium
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) premiumpremium premiumpremium
11901 Injection into skin growth, more than 7 growths premiumpremium premiumpremium
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm premiumpremium premiumpremium
17263 Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm premiumpremium premiumpremium
40490 Biopsy of lip premiumpremium premiumpremium
69100 Biopsy of ear premiumpremium premiumpremium
96567 Application of light to destroy precancer skin growth premiumpremium premiumpremium
11303 Shaving of skin growth of body, arms, or legs, more than 2.0 cm premiumpremium premiumpremium
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm premiumpremium premiumpremium
11622 Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm premiumpremium premiumpremium
11105 Punch biopsy, each additional skin growth premiumpremium premiumpremium
11300 Shaving of skin growth of body, arms, or legs, 0.5 cm or less premiumpremium premiumpremium
11305 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less premiumpremium premiumpremium
10060 Simple or single drainage of skin abscess premiumpremium premiumpremium
13101 Complicated repair of wound of trunk, 2.6-7.5 cm premiumpremium premiumpremium
Q0112 All potassium hydroxide (koh) preparations premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.